CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Nicotine Replacement Therapy Products
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
4.2.4.1 Nicotine Lozenges Market size and forecast, by region
4.2.4.2 Nicotine Gums Market size and forecast, by region
4.2.4.3 Nicotine Sprays Market size and forecast, by region
4.2.4.4 Nicotine Inhalers Market size and forecast, by region
4.3 Drug Therapy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 E-cigarettes
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM
5.1 Overview
5.1.1 Market size and forecast
5.2 Gum
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Inhaler
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Tablet
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Online Provider
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug stores and Retail Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.2.3 North America Market size and forecast, by Form
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Form
7.2.5.1.3 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Form
7.2.5.2.3 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Form
7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.3.3 Europe Market size and forecast, by Form
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Form
7.3.5.1.3 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Form
7.3.5.2.3 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Form
7.3.5.3.3 Market size and forecast, by Distribution Channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Form
7.3.5.4.3 Market size and forecast, by Distribution Channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Form
7.3.5.5.3 Market size and forecast, by Distribution Channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Form
7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Form
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Form
7.4.5.1.3 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Form
7.4.5.2.3 Market size and forecast, by Distribution Channel
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Form
7.4.5.3.3 Market size and forecast, by Distribution Channel
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Form
7.4.5.4.3 Market size and forecast, by Distribution Channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Form
7.4.5.5.3 Market size and forecast, by Distribution Channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Form
7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.5.3 LAMEA Market size and forecast, by Form
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Form
7.5.5.1.3 Market size and forecast, by Distribution Channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Form
7.5.5.2.3 Market size and forecast, by Distribution Channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Form
7.5.5.3.3 Market size and forecast, by Distribution Channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Form
7.5.5.4.3 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 British American Tobacco Plc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 22nd Century group Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cipla Ltd.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Dr. Reddy’s Laboratories Ltd.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 GlaxoSmithKline Plc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Imperial Brands Plc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Johnson and Johnson Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Njoy Company
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Perrigo Company Plc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Pfizer Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Zydus Cadila, Inc.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Rusan Pharma Ltd
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
| ※参考情報 禁煙およびニコチン依存症治療製品は、タバコの喫煙をやめたいと考える人々を支援するために開発されたさまざまな製品や治療法を指します。このような製品は、ニコチン依存症を克服し、健康的なライフスタイルを取り戻す手助けを目的としています。 禁煙治療製品には、大きく分けてニコチン置換療法（NRT）と非ニコチン系治療法があります。ニコチン置換療法は、タバコを吸うことで得られるニコチンの喪失感を軽減するための製品で、主にニコチンパッチ、ニコチンガム、ニコチン吸入器、ニコチンロゼンジなどがあります。これらの製品は、体内に少量のニコチンを供給することで、禁煙による禁断症状や craving を和らげる役割を果たします。ニコチンパッチは、皮膚に貼ることで一定のニコチンを時間をかけて放出し、身体のニコチンレベルを安定させるもので、使いやすく効果的な方法として人気があります。 一方、非ニコチン系治療法には、バレニクリンやブプロピオンなどの医薬品が含まれます。バレニクリンは、脳内のニコチン受容体に作用し、ニコチンの代わりに作用することで禁断症状を和らげるとともに、タバコの喫煙時に感じる快感を減少させる作用があります。ブプロピオンは、抗うつ薬としても使われる医薬品で、ニコチン受容体に影響を与え、禁煙のための強力な促進剤として利用されます。 これらの禁煙治療製品は、主に医療機関やドラッグストアなどで入手可能です。治療前には、医師や薬剤師と相談することが推奨されています。禁煙を始めるタイミングや、使う製品の種類は、個人の喫煙歴やニコチン依存の度合いによって異なります。 禁煙治療製品の用途は、禁煙を助けるだけでなく、タバコが引き起こす様々な健康リスクを軽減することにもあります。喫煙が原因となる疾患には、肺がん、慢性閉塞性肺疾患、心疾患などがあり、禁煙によってこれらの疾患のリスクを大幅に低下させることができます。また、禁煙は社会的、経済的な利益も生むため、個人にとっても、社会全体にとっても重要な取り組みとなります。 関連技術としては、禁煙を支援するアプリやオンラインサポートも増えています。これらのデジタルツールは、ユーザーが禁煙計画を立てたり、進捗を記録したりすることができる機能を提供しています。例えば、毎日の禁煙進捗やタバコを吸わなかった日数を記録することで、達成感を得ることができます。また、励ましのメッセージや禁煙に関する情報を提供することもあります。 さらに、禁煙プログラムやカウンセリングも重要な要素となっています。継続的なサポートを受けることで、禁煙に対する意志を保つことができ、成功率を高めることができます。特に、集団プログラムや個人カウンセリングなど、他者とのコミュニケーションを通じて情報交換や体験を共有することは、強い支えとなります。 禁煙治療製品や関連技術は、個人の状況に応じて最適な方法を見つけるための手助けをし、禁煙成功への道を拓くことが期待されています。このような製品やサポートを活用することで、喫煙からの解放を目指して、より良い未来を手に入れることができるのです。タバコをやめることは簡単なことではありませんが、正しい方法と支援を得ることで、実現可能な目標となるでしょう。 |
